纳米医学
纳米颗粒
纳米技术
材料科学
癌症
癌细胞
癌症研究
肿瘤细胞
生物
遗传学
作者
Bakhtawar Bukhari,Muhammad Naveed,Syeda Izma Makhdoom,Khizra Jabeen,Muhammad Farrukh Asif,Hira Batool,Naveed Ahmed,Chan Yean Yean
出处
期刊:NANO
[World Scientific]
日期:2021-10-12
卷期号:16 (13)
被引量:17
标识
DOI:10.1142/s1793292021300115
摘要
In the modern era, nanotechnology is one of the rapidly growing fields in many biomedical applications especially in delivering therapeutics for the curation of tumor cells. Cancer is a lethal disease that grows silently in the human body, caused by mutations in the genetic material of cells. The presence of a high number of physiologically active chemicals on the cancer cell surface does not particularly lead to tumor cell targeting. The lack of effective targeting of tumor cells by conventionally administered chemotherapeutic drugs demands the use of nanomedicine. Conventional medicines have immense cytotoxic effects, i.e., they do not kill tumor cells only but also destroy normal body cells. Nanoparticles (NPs) have an advantage over conventional therapeutic methods due to their small size, large surface area, and especially for targeting tumor cells without harming normal body cells. Based on durability and molecular weight, NPs are classified as organic and inorganic nanoparticles. Common organic and inorganic nanoparticles are highly effective against cancer curation and have high efficacy values along with their mechanism of action.
科研通智能强力驱动
Strongly Powered by AbleSci AI